The Use of Molecular Biomarker Tests: An Interview Study with Healthcare Providers about a Molecular Biomarker Test for Prostate Cancer

References

• Chong HY , AlloteyPA , ChaiyakunaprukN. Current landscape of personalized medicine adoption and implementation in Southeast Asia. BMC Medical Genom.11, 94 (2018).
   PubMed Web of Science ®Google Scholar
• Alford AV , BritoJM , YadavKK , YadavSS , TewariAK , RenzulliJ. The use of biomarkers in prostate cancer screening and treatment. Rev. Urol.19(4), 221–234 (2017).
   PubMedGoogle Scholar
• Bangash H , KulloIJ. Implementation science to increase adoption of genomic medicine: an urgent need. J. Pers. Med.11, 19 (2021).
   Web of Science ®Google Scholar
• Strohm L , HehakyaC , RanschaertER , BoonWPC , MoorsEHM. Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors. Eur. Radiol.30, 5525–5532 (2020).
   PubMed Web of Science ®Google Scholar
• Greenhalgh T , WhertonJ , PapoutsiCet al. Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies. J. Med. Internet. Res.19(11), e367 (2017).
   PubMed Web of Science ®Google Scholar
• Abrishami P , BoerA , HorstmanK. Understanding the adoption dynamics of medical innovations: affordances of the da Vinci robot in the Netherlands. Soc. Sci. Med.117, 125–133 (2014).
   PubMed Web of Science ®Google Scholar
• Manolio TA , ChisholmRL , OzenbergerBet al. Implementing genomic medicine in the clinic: the future is here. Genet. Med.15(4), 258–267 (2013).
   PubMed Web of Science ®Google Scholar
• Delaney SK , ChristmanMF. Encouraging physician adoption of genetic testing for precision medicine. Per. Med.13(3), 201–204 (2016).
   PubMed Web of Science ®Google Scholar
• Pritchard DE , MoeckelF , VillaMS , HousmanLT , McCartyCA , McLeodHL. Strategies for integrating personalized medicine into healthcare practice. Per. Med.14(2), 141–152 (2017).
   PubMed Web of Science ®Google Scholar
• Bombard Y , RozmovitsL , TrudeauM , LeighlN , DealK , MarshallD. The value of personalizing medicine: medical oncologists’ views on gene expression profiling in breast cancer treatment. Oncologist20, 351–356 (2015).
   PubMed Web of Science ®Google Scholar
• O’Brien MA , Dhesy-ThindS , CharlesC , HammondMobilio M , LeighlNB , GrunfeldE. Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists. Curr. Oncol.24(2), e138–e145 (2017).
   PubMed Web of Science ®Google Scholar
• Pirmohamed M . Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles. Trans. Med.88(6), 862–866 (2010).
   Google Scholar
• Haese A , TrooskensG , SteyaertSet al. Multicenter optimization and validation of a 2-gene mRNA urine test for detection of clinically significant prostate cancer before initial prostate biopsy. J. Urol.202, 256–263 (2019).
   PubMed Web of Science ®Google Scholar
• Hendriks RJ , Vander Leest MMG , DijkstraSet al. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection. Prostate77, 1401–1407 (2017).
   PubMed Web of Science ®Google Scholar
• Van Neste L , HendriksRJ , DijkstraSet al. Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score. Eur. Urol.70, 740–748 (2016).
   PubMed Web of Science ®Google Scholar
• Govers TM , HesselsD , Vlaeminck-GuillemVet al. Cost–effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study. Prostatic Dis.22(1), 101–109 (2018).
   PubMed Web of Science ®Google Scholar
• Dijkstra S , GoversTM , HendriksRJet al. Cost–effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics – a decision analytical model. BJU Int.120(5), 659–665 (2017).
   PubMed Web of Science ®Google Scholar
• Filella X , Fernández-GalanE , FernándezBonifacio R , FojL. Emerging biomarkers in the diagnosis of prostate cancer. Pharmacogenom. Per. Med.11, 83–94 (2018).
   PubMed Web of Science ®Google Scholar
• Kornberg Z , CooperbergMR , SprattDE , FengFY. Genomic biomarkers in prostate cancer. Transl. Androl. Urol.7(3), 459–471 (2018).
   PubMed Web of Science ®Google Scholar
• McGrath S , ChristidisD , PereraMet al. Prostate cancer biomarkers: are we hitting the mark? Prostate Int. 4, 130–135 (2016).
   PubMedGoogle Scholar
• Gandaglia G , AlbersP , AbrahamssonPAet al. Structured population-based prostate-specific antigen screening for prostate cancer: The European Association of Urology Position in 2019. Eur. Urol.76(2), 142–150 (2019).
   PubMed Web of Science ®Google Scholar
• Loeb S , BjurlinMA , NicholsonJ , TammelaTL , PensonDF , CarterHB. Overdiagnosis and overtreatment of prostate cancer. Eur. Urol.65(6), 1046–1055 (2014).
   PubMed Web of Science ®Google Scholar
• Van Poppel H , HogenhoutR , AlbersPet al. Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European Union and the European Commission. Eur. Urol.79(3), 327–329 (2020).
   PubMed Web of Science ®Google Scholar
• Vaismoradi M , TurunenH , BondasT. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs. Health Sci.15, 398–405 (2013).
   PubMed Web of Science ®Google Scholar
• Zorginstituut Nederland . Medisch Specialistische Zorg (Zvw) (2021). http://www.zorginstituutnederland.nl/Verzekerde+zorg/medisch-specialistische-zorg-zvw
   Google Scholar
• Nederlandse Vereniging voor Urologie . Prostaatcarcinoom – Diagnostiek (2014). https://richtlijnendatabase.nl/richtlijn/prostaatcarcinoom/diagnostiek.html
   Google Scholar
• Mottet N , Vanden Bergh RCN , DeSantis Met al. EAU Guidelines Prostate Cancer (2019). https://uroweb.org/guideline/prostate-cancer/#5
   Google Scholar
• Schrijvers G , Van HoornA , HuiskesN. The care pathway: concepts and theories: an introduction. Int. J. Integr. Care.12, e192 (2012).
   PubMed Web of Science ®Google Scholar
• Davis FD . Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q13(3), 318–340 (1989).
   Web of Science ®Google Scholar
• Urquhart R , KendellC , GeldenhuysLet al. The role of scientific evidence in decisions to adopt complex innovations in cancer care settings: a multiple case study in Nova Scotia, Canada. Implement. Sci.14, Article Number 14 (2019). https://implementationscience.biomedcentral.com/articles/10.1186/s13012-019-0859-5
   PubMed Web of Science ®Google Scholar
• Turner S , D’LimaD , HudsonEet al. Evidence use in decision-making on introducing innovations: a systematic scoping review with stakeholder feedback. Implement. Sci.12, Article number 145 (2017). https://implementationscience.biomedcentral.com/articles/10.1186/s13012-017-0669-6
   Web of Science ®Google Scholar
• Rycroft RW , KashDE. Path dependence in innovation of complex technologies. Technol. Anal. Strateg. Manag.14(1), 21–35 (2002).
   Web of Science ®Google Scholar
• Bell K . Biomarkers, the molecular gaze and the transformation of cancer survivorship. Biosocieties8(2), 124–143 (2013).
   PubMed Web of Science ®Google Scholar
• Joyce KA . Painting by numbers: the development of magnetic resonance imaging and the visual turn in medicine. In: Magnetic Appeal: MRI and the Myth of Transparency.Magnetic Appeal: MRI and the Myth of Transparency.Cornell University Press, NY, USA, 24–46 (2008).
   Google Scholar
• Krabbenborg L . Dramatic rehearsal on the societal embedding of the lithium chip. In: Ethics on the Laboratory Floor.Vander Burg S, SwierstraT ( Eds). Palgrave Macmillan, London, UK, 168–187 (2013).
   Google Scholar
• Geels FW . From sectoral systems of innovation to sociotechnical systems: insights about dynamics and change from sociology and institutional theory. Res. Policy33(6–7), 897–920 (2004).
   Web of Science ®Google Scholar
• Moors EM , RipA , WiskerkeH. The dynamics of innovation: a multilevel co-evolutionary perspective. In: Seeds of Transition. Essays on Novelty Production, Niches and Regimes in Agriculture.WiskerkeJSC, Vander Ploeg JD ( Eds). Van Gorcum, Assen, The Netherlands, 31–56 (2004).
   Google Scholar
• Oudshoorn N . Diagnosis at a distance: the invisible work of patients and healthcare professionals in cardiac telemonitoring technology. Soc. Health Ill.30(2), 272–288 (2008).
   PubMed Web of Science ®Google Scholar
• Piras EM , MieleF. Clinical self-tracking and monitoring technologies: negotiations in the ICT-mediated patient–provider relationship. Health Soc. Rev.26(1), 38–53 (2017).
   Web of Science ®Google Scholar
• Pols J , WillemsD. Innovation and evaluation: taming and unleashing telecare technology. Soc. of Health Illn.33(3), 484–498 (2011).
   PubMed Web of Science ®Google Scholar
• Garud R , AhlstromD. Technology assessment: a socio-cognitive perspective. J. Eng. Technol. Manag.14(1), 25–48 (1997).
   Web of Science ®Google Scholar
• Yin RK . Case study methods. In: APA Handbook of Research Methods in Psychology: Vol. 2 Research Designs.CooperH ( Ed.). American Psychological Association, MA, USA, 141–155 (2012).
   Google Scholar